Specialty Pharmacy

Top news of the day from across the health care landscape.

B cells activate T cells in the blood to cause inflammation and brain lesions in patients with multiple sclerosis.

One in 5 test results showed potentially dangerous concurrent use of opioids and benzodiazepines in 2017.

With Hurricane Florence about to strike, pharmacies must take extra steps to maintain services for patients in need of lifesaving medications.

Early-life obesity increases the risk of several different types of cancer developing later in life.

Top news of the day from across the health care landscape.

In its multiple-ascending dose trial, ARO-HBV demonstrated reductions in circulating hepatitis B virus surface antigen.

Study identifies a potential association between azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma.

The FDA is taking new steps to better ensure the quality of compounded drugs, while also preserving patient access to these medications.

Top news of the day from across the health care landscape.

Treatment with tezepelumab reduced annual asthma exacerbation rates in patients with severe asthma without an eosinophilic phenotype.

Treatment with ibudilast reduced the progression of brain atrophy in patients with progressive multiple sclerosis compared with a placebo.

Officials with the FDA have approved a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film for the maintenance treatment of opioid dependence.

Top news of the day from across the health care landscape.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses the potential for specialty pharmacies to become the norm.

The new formulation is the only immune globulin available in the United States that is approved for post-exposure protection against hepatitis A and measles.

Ozanimod reduced the number of brain lesions and lowered relapse rates in patients with relapsing multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.

The approval of riluzole oral suspension fills a therapeutic need for patients with amyotrophic lateral sclerosis who develop swallowing impairment.

Hub services act to simplify the complexity and perform as an intermediary between involved parties.

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection.

Through their Medicaid and Ryan White HIV/AIDS Programs, states play an integral role in ensuring access to care for people living with HIV.

Study provides insight into how cannabidiol acts in the brain to reduce psychotic symptoms.

Top news of the day from across the health care landscape.

New report assesses the quality of rheumatic disease care across all 50 states and calls for improvements that address access to affordable care.